Literature DB >> 12544693

Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium.

Sarah C Cobbe1, Gillian C Scobie, Elizabeth Pohler, John D Hayes, Neil M Kernohan, John F Dillon.   

Abstract

OBJECTIVE: Oesophageal cancer associated with the premalignant condition Barrett's oesophagus has increased in incidence over the last few years. Phase II detoxifying enzymes, including glutathione S-transferases (GSTs) protect the mucosa from carcinogens, which can cause oxidative damage to cells. Therefore, a reduction in these anti-oxidant enzymes can increase the risk of carcinogenesis. The aim of this study was to compare the extent of GST expression in normal oesophageal tissue, Barrett's oesophagus and oesophageal adenocarcinoma.
DESIGN: Antibodies raised against GST alpha, GST mu, GST pi and microsomal GST were used to identify expression of these proteins in tissue sections.
METHOD: Paraffin-embedded sections were stained using standard immunohistochemical techniques to demonstrate the pattern of expression of GST proteins in biopsy specimens. Twelve sections of Barrett's metaplasia and an equal number of specimens from normal oesophageal tissue were examined, together with sections from adenocarcinoma and normal gastric mucosa.
RESULTS: Expression of the GST enzymes appeared to be reduced in Barrett's tissue compared to normal oesophageal tissue. Nuclear staining featured in some of the normal tissue sections, but not in Barrett's tissue.
CONCLUSION: The reduction in GST expression suggested in Barrett's tissue is an interesting finding, as it is possible that reduced expression of these detoxifying enzymes may contribute to the risk of development of adenocarcinoma in Barrett's mucosa. Copyright 2002 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544693     DOI: 10.1097/00042737-200301000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Authors:  Laszlo Herszenyi; Istvan Hritz; Istvan Pregun; Ferenc Sipos; Mark Juhasz; Bela Molnar; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 2.  Esophageal adenocarcinoma arising in Barrett esophagus.

Authors:  Hui Ying Zhang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Cancer Lett       Date:  2008-08-13       Impact factor: 8.679

3.  Association between gene expression of metabolizing enzymes and esophageal squamous cell carcinomas in China.

Authors:  Ran Liu; Lihong Yin; Yuepu Pu
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-01

4.  Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.

Authors:  Zhihui Wang; Wei He; Guanrui Yang; Junsheng Wang; Zhong Wang; Jahn M Nesland; Ruth Holm; Zhenhe Suo
Journal:  BMC Cancer       Date:  2010-07-05       Impact factor: 4.430

5.  Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.

Authors:  Yaping Zhao; Furu Wang; Shunlin Shan; Yiqi Zhao; Xueming Qiu; Xiangyang Li; Feng Jiao; Jianguo Wang; Yunxiang Du
Journal:  Int J Med Sci       Date:  2010-09-01       Impact factor: 3.738

6.  A phase I pilot study evaluating the beneficial effects of black raspberries in patients with Barrett's esophagus.

Authors:  Laura A Kresty; John J Fromkes; Wendy L Frankel; Cynthia D Hammond; Navindra P Seeram; Maureen Baird; Gary D Stoner
Journal:  Oncotarget       Date:  2016-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.